Trial · NCT01949324
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ellipsoid zone (area of IS/OS loss) as measured by en face imagining by SDOCT in study eye(s) | 24 months | Change in the ellipsoid zone (area of IS/OS loss) from baseline to month 24 as measured by en face imaging by SDOCT in study eye(s) |
| Secondary | Ellipsoid zone | 12 months | Change in the ellipsoid zone from baseline to Month 12. |
| Secondary | Retinal sensitivity (dB) as measured by microperimetry | 12 and 24 months | Change in retinal sensitivity (dB) as measured by microperimetry from baseline to Months 12 and 24. |
| Secondary | Increase in ellipsoid zone | 12 and 24 months | Proportion of study eyes with a 35% or more increase from baseline in the ellipsoid zone at Months 12 and 24. |
| Secondary | Visual Acuity | 12 and 24 months | Change in best corrected visual acuity (BCVA) from baseline to Months 12 and 24. |
| Secondary | Visual Acuity | 12 and 24 Months | Proportion of study eyes with 15 or more letter loss from baseline in BCVA at Months 12 and 24. |
| Secondary | Visual Acuity | 12 and 24 Months | Proportion of study eyes with 10 or more letter loss from baseline in BCVA at Months 12 and 24. |
| Secondary | Reading Speed | 12 and 24 Months | Change in reading speed as measured by the IReST from baseline to Months 12 and 24. |
| Other | Cone density as measured by AOSLO | 12 and 24 Months | Change in cone density as measured by AOSLO from baseline to Months 12 and 24, in selected participants. |
| Other | National Eye Institute Visual Functioning Questionnaire | 12 and 24 months | Change in NEI VFQ (overall and subscale) from baseline to Months 12 and 24. |
| Other | Electroretinogram changes | 6, 12 and 24 Months | Electroretinogram (ERG) changes from baseline to Months 6, 12 and 24, in selected clinics/participants. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01949324/registered